Grail, Inc. (NASDAQ:GRAL - Get Free Report) shares traded up 8.2% during trading on Thursday . The company traded as high as $28.92 and last traded at $28.84. 248,290 shares were traded during mid-day trading, a decline of 75% from the average session volume of 993,628 shares. The stock had previously closed at $26.67.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. Guggenheim initiated coverage on Grail in a research report on Thursday, October 17th. They set a "neutral" rating on the stock. Morgan Stanley initiated coverage on shares of Grail in a research report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price objective for the company. Finally, Wolfe Research began coverage on Grail in a research report on Friday, November 15th. They issued a "peer perform" rating on the stock.
Get Our Latest Analysis on Grail
Grail Price Performance
The company has a 50-day simple moving average of $20.34 and a 200-day simple moving average of $16.64.
Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The business had revenue of $28.65 million for the quarter. As a group, equities analysts expect that Grail, Inc. will post -65.16 EPS for the current fiscal year.
Insiders Place Their Bets
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares of the company's stock, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Institutional Trading of Grail
Several hedge funds have recently added to or reduced their stakes in GRAL. abrdn plc acquired a new stake in Grail during the 4th quarter valued at $3,768,000. Douglas Lane & Associates LLC acquired a new stake in Grail in the fourth quarter valued at $3,034,000. Slow Capital Inc. bought a new position in Grail in the 4th quarter valued at about $2,379,000. 180 Wealth Advisors LLC acquired a new position in Grail in the 4th quarter valued at $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new stake in Grail in the 4th quarter worth about $559,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
